RESUSCITATION OF TRAUMATIC HEMORRHAGIC SHOCK PATIENTS WITH HYPERTONIC SALINE-WITHOUT DEXTRAN-INHIBITS NEUTROPHIL AND ENDOTHELIAL CELL ACTIVATION

被引:94
作者
Junger, Wolfgang G. [1 ,2 ]
Rhind, Shawn G. [3 ]
Rizoli, Sandro B. [4 ]
Cuschieri, Joseph [5 ]
Shiu, Maria Y. [4 ]
Baker, Andrew J. [6 ]
Li, Linglin [1 ,2 ]
Shek, Pang N. [3 ]
Hoyt, David B. [7 ]
Bulger, Eileen M. [5 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA
[2] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Def Res & Dev Canada, Toronto, ON, Canada
[4] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg & Crit Care Med, Toronto, ON, Canada
[5] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA
[6] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst,Brain Injury Lab, Cara Phelan Ctr Trauma Res,Keenan Res Ctr, Toronto, ON M5B 1W8, Canada
[7] Univ Calif Irvine, Dept Surg, Amer Coll Surg, Irvine, CA 92717 USA
来源
SHOCK | 2012年 / 38卷 / 04期
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Hypertonic saline; resuscitation fluids; hemorrhage; neutrophils; adhesion molecules; inflammation; multiorgan failure; matrix metalloproteinase; myeloperoxidase; shock; RECEPTOR EXPRESSION; ADENOSINE; RELEASE; SEPSIS; INJURY; P2; SEVERITY; ADHESION; FLUIDS; DAMAGE;
D O I
10.1097/SHK.0b013e3182635aca
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Posttraumatic inflammation and excessive neutrophil activation cause multiple organ dysfunction syndrome (MODS), a major cause of death among hemorrhagic shock patients. Traditional resuscitation strategies may exacerbate inflammation; thus, novel fluid treatments are needed to reduce such posttraumatic complications. Hypertonic resuscitation fluids inhibit inflammation and reduce MODS in animal models. Here we studied the anti-inflammatory efficacy of hypertonic fluids in a controlled clinical trial. Trauma patients in hypovolemic shock were resuscitated in a prehospital setting with 250 mL of either 7.5% hypertonic saline (HS; n = 9), 7.5% hypertonic saline + 6% dextran 70 (HSD; n = 8), or 0.9% normal saline (NS; n = 17). Blood samples were collected on hospital admission and 12 and 24 h after resuscitation. Multicolor flow cytometry was used to quantify neutrophil expression of cell-surface activation/adhesion (CD11b, CD62L, CD64) and degranulation (CD63, CD66b, CD35) markers as well as oxidative burst activity. Circulating concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVACM-1), P- and E-selectins, myeloperoxidase (MPO), and matrix metalloproteinase 9 (MMP-9) were assessed by immunoassay. Multiple organ dysfunction syndrome, leukocytosis, and mortality were lower in the HS and HSD groups than in the NS group. However, these differences were not statistically significant. Hypertonic saline prevented priming and activation and neutrophil oxidative burst and CD11b and CD66b expression. Hypertonic saline also reduced circulating markers of neutrophil degranulation (MPO and MMP-9) and endothelial cell activation (sICAM-1, sVCAM-1, soluble E-selectin, and soluble P-selectin). Hypertonic saline + 6% dextran 70 was less capable than HS of suppressing the upregulation of most of these activation markers. This study demonstrates that initial resuscitation with HS, but neither NS nor HSD, can attenuate posttraumatic neutrophil and endothelial cell activation in hemorrhagic shock patients. These data suggest that hypertonic resuscitation without dextran may inhibit posttraumatic inflammation. However, despite this effect, neither HS nor HSD reduced MODS in trauma patients with hemorrhagic shock.
引用
收藏
页码:341 / 350
页数:10
相关论文
共 36 条
[1]
Bench-to-bedside review: Latest results in hemorrhagic shock [J].
Angele, Martin K. ;
Schneider, Christian P. ;
Chaudry, Irshad H. .
CRITICAL CARE, 2008, 12 (04)
[2]
Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression - Discussion [J].
West, MA ;
Maier, RV ;
Angle, N .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1998, 45 (01) :12-13
[3]
Hypertonic saline infusion: Can it regulate human neutrophil function? [J].
Angle, N ;
Cabello-Passini, R ;
Hoyt, DB ;
Loomis, WH ;
Shreve, A ;
Namiki, S ;
Junger, WG .
SHOCK, 2000, 14 (05) :503-508
[4]
RETRACTED: Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients (Retracted Article) [J].
Boldt, J ;
Muller, M ;
Kuhn, D ;
Linke, LC ;
Hempelmann, G .
INTENSIVE CARE MEDICINE, 1996, 22 (02) :122-128
[5]
Early predictors of morbidity and mortality in trauma patients treated in the intensive care unit [J].
Brattstrom, O. ;
Granath, F. ;
Rossi, P. ;
Oldner, A. .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2010, 54 (08) :1007-1017
[6]
Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock [J].
Bulger, Eileen M. ;
Cuschieri, Joseph ;
Warner, Keir ;
Maier, Ronald V. .
ANNALS OF SURGERY, 2007, 245 (04) :635-641
[7]
INCREASED NEUTROPHIL ADENOSINE A3 RECEPTOR EXPRESSION IS ASSOCIATED WITH HEMORRHAGIC SHOCK AND INJURY SEVERITY IN TRAUMA PATIENTS [J].
Bulger, Eileen M. ;
Tower, Cindy M. ;
Warner, Keir J. ;
Garland, Tara ;
Cuschieri, Joseph ;
Rizoli, Sandro ;
Rhind, Shawn ;
Junger, Wolfgang G. .
SHOCK, 2011, 36 (05) :435-439
[8]
7.5% Saline and 7.5% Saline/6% Dextran for Hypovolemic Shock [J].
Bulger, Eileen M. .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2011, 70 (05) :S27-S29
[9]
Out-of-hospital Hypertonic Resuscitation After Traumatic Hypovolemic Shock A Randomized, Placebo Controlled Trial [J].
Bulger, Eileen M. ;
May, Susanne ;
Kerby, Jeffery D. ;
Emerson, Scott ;
Stiell, Ian G. ;
Schreiber, Martin A. ;
Brasel, Karen J. ;
Tisherman, Samuel A. ;
Coimbra, Raul ;
Rizoli, Sandro ;
Minei, Joseph P. ;
Hata, J. Steven ;
Sopko, George ;
Evans, David C. ;
Hoyt, David B. .
ANNALS OF SURGERY, 2011, 253 (03) :431-441
[10]
Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors [J].
Chen, Y ;
Hashiguchi, N ;
Yip, L ;
Junger, WG .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (04) :C1051-C1059